BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30446355)

  • 1. Acutely decompensated heart failure with chronic obstructive pulmonary disease: Clinical characteristics and long-term survival.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Raimondo R; Venezia M; Frigerio M
    Eur J Intern Med; 2019 Feb; 60():31-38. PubMed ID: 30446355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study.
    Fisher KA; Stefan MS; Darling C; Lessard D; Goldberg RJ
    Chest; 2015 Mar; 147(3):637-645. PubMed ID: 25188234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
    Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
    Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
    Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of comorbidities in hospitalized patients with acute exacerbation of chronic heart failure.
    Scrutinio D; Passantino A; Guida P; Ammirati E; Oliva F; Braga SS; La Rovere MT; Lagioia R; Frigerio M
    Eur J Intern Med; 2016 Oct; 34():63-67. PubMed ID: 27263064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
    J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive airway disease among patients hospitalized with acute heart failure; clinical characteristics, precipitating factors, management and outcome: Observational report from the Middle East.
    Khafaji HA; Sulaiman K; Singh R; Alhabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; Almahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; Faleh HA; Elasfar A; Panduranga P; Suwaidi JA
    Acute Card Care; 2015 Dec; 17(4):55-66. PubMed ID: 27712142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic influence of prior chronic obstructive pulmonary disease in patients admitted for their first episode of acute heart failure.
    Londoño KL; Formiga F; Chivite D; Moreno-Gonzalez R; Migone De Amicis M; Corbella X
    Intern Emerg Med; 2018 Apr; 13(3):351-357. PubMed ID: 29508227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure.
    Rusinaru D; Saaidi I; Godard S; Mahjoub H; Battle C; Tribouilloy C
    Am J Cardiol; 2008 Feb; 101(3):353-8. PubMed ID: 18237599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.
    Lainscak M; Hodoscek LM; Düngen HD; Rauchhaus M; Doehner W; Anker SD; von Haehling S
    Wien Klin Wochenschr; 2009; 121(9-10):309-13. PubMed ID: 19562292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
    Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
    BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female gender and mortality risk in decompensated heart failure.
    Scrutinio D; Guida P; Passantino A; Lagioia R; Raimondo R; Venezia M; Ammirati E; Oliva F; Stucchi M; Frigerio M
    Eur J Intern Med; 2018 May; 51():34-40. PubMed ID: 29317139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD predicts mortality in HF: the Norwegian Heart Failure Registry.
    De Blois J; Simard S; Atar D; Agewall S;
    J Card Fail; 2010 Mar; 16(3):225-9. PubMed ID: 20206897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
    Katz A; Maor E; Leor J; Klempfner R
    Int J Cardiol; 2016 Oct; 221():198-204. PubMed ID: 27404675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.